Sept. 20 — The State Administration for Market Regulation (SAMR) said at a State Council Information Office briefing it will align online and offline supervision, accelerate construction of a national unified product quality-safety traceability system, and tighten platform responsibilities for verifying product listings and cooperating with recalls. SAMR said it will carry out a targeted enforcement campaign on the quality and safety of industrial products sold online and step up crackdowns on i

MS NOW said a reporter was denied entry to White House grounds today and that the outlet will take all necessary measures to defend its First Amendment rights. The statement follows President Trump’s announcement effective today barring CNN, MS NOW and Politico from White House access, citing those outlets’ long-running publication of "fake news."

Sept. 20 — China’s National Medical Products Administration deputy director Yang Sheng told a State Council press briefing the agency will implement drug trial data protection and establish market exclusivity periods for pediatric medicines and rare-disease treatments to better safeguard firms’ R&D investment. The NMPA will improve early-stage R&D communication, providing stronger pre-submission guidance for drugs with new targets or novel mechanisms. It will also expand a Spring Rain initiative to accelerate clinical translation of medical-device innovation and issue clinical trial and review guidance for frontier areas such as brain–computer interfaces to lay groundwork for future industry development.